Article citationsMore>>

E. Klyuchnikov, N. Kroger, H. Brummendorf, A. Wiedemann and A. U. Bacher, “Current Status and Perspectives of Tyrosine Kinase Inhibitor Treatment in the Posttransplant Period in Patients with Chronic Myelogenous Leukemia (CML),” Biology Blood Marrow Transplantation, Vol. 16, No. 3, 2010, pp. 301-310. doi:10.1016/j.bbmt.2009.08.019

has been cited by the following article:

SCIRP Newsletter
Copyright © 2006-2026 Scientific Research Publishing Inc. All Rights Reserved.
Top